Jaswinder S Chadha
President & CEO
Jassi Chadha, President & CEO, Jassi co-founded marketRx with the vision of bringing cutting-edge analytics and interactive technology to the healthcare marketing arena. Jassi has led marketRx's strategic direction since its inception in 2000. Jassi is a pioneer in building advanced analytical software tools for designing pharmaceutical sales forces.

He has provided marketing strategies to a number of major global pharmaceutical clients, in virtually every major therapeutic category. Clients value his intelligence, perspective and commitment to the highest quality of service. In recognition of his leadership and entrepreneurial achievements, Jassi was awarded the year 2003 "Top Forty under Forty" by NJBiz Magazine and is a current year winner in the E&Y "Entrepreneur of the Year" program.

In addition, New Jersey Technology Council (NJTC) awarded marketRx the Prestigious "Private Company of the Year" in January 2003. NJBIZ has also named marketRx as one of the "Finest" Companies in New Jersey for the year 2003.

Before co-founding marketRx Inc, Jassi was a Director of Strategic Promotional Planning for a healthcare consulting company. Jassi was a Doctoral candidate in Operations Research at Texas A&M University and received his B.Tech in Mechanical Engineering from the Indian Institute of Technology, Delhi.

Amarpreet Sawhney PhD
President & CEO, Confluent Surgical Inc.
Dr. Sawhney is currently the President and CEO of Confluent Surgical and Managing Directors in Incept LLC. His inventions have formed the basis for the founding of several medical device and biotechnology companies and their products. These include for example, the in-situ polymerized surgical sealant products that are currently being developed and marketed by Focal Inc. of Lexington, MA, (acquired by Genzyme) where he recently held the position of Director and Technology Founder. Other companies that are pursuing technologies that have been co-invented by Dr. Sawhney include Novacell of Santa Ana, CA which is developing biohybrid organs for transplantation and Infimed Inc. of Cambridge, MA which is developing controlled release systems for drug delivery. He personally holds over 35 patents and has authored over 85 publications and scientific abstracts. Dr. Sawhney holds a Ph.D. in Chemical Engineering from University of Texas and a B.Tech from the Indian Institute of Technology, Delhi.

L. Nelson Hopkins MD
Director of the Toshiba Stroke Research Center, SUNY Buffalo
Dr. Hopkins is Professor and Chairman of Neurosurgery, Professor of Radiology, and Director of the Toshiba Stroke Research Center at the State University of New York at Buffalo. A noted expert in cerebrovascular disease, Dr. Hopkins is frequently invited to speak at national and international scientific meetings. He has addressed forums in Europe, Asia, and North, South, Central America and Africa. He serves on the medical advisory board of several medical device companies. Active in national neurosurgery, Dr. Hopkins has served on numerous national boards and committees. He has served as Chairman of the Scientific Program and is a Board Member of both The American Association of Neurological Surgeons (AANS), and The Congress of Neurological Surgeons (CNS). He currently serves as Secretary of the Academy of Neurological Surgery. He has also served as a member of the Executive Committee of the Stroke Council of the American Heart Association (AHA). He is a member of the editorial board of Neurosurgery.

Rick S. Braddock
Partner at Mid Ocean Partners
Rick Braddock has joined MidOcean Partners as a partner recently. He is also serving as a Chairman of the Board of Directors of priceline.com since August 1998 and was most recently Chief Executive Officer of the company from May 2001 to November 2002 and from August 1998 to May 2000. From 1973 to 1992, Mr. Braddock held a variety of positions at Citicorp and its principal subsidiary, Citibank, N.A., including President and Chief Operating Officer. Mr. Braddock also served as CEO of Medco Containment Services, non-executive Chairman of True North Communications, Inc., and special advisor to General Atlantic Partners LLC. Mr. Braddock also serves as Director of Eastman Kodak Company, Cadbury Schweppes plc, MphasiS-BFL Limited, Lincoln Center for the Performing Arts and Lennox Hill Hospital, and is a trustee of the Cancer Research Institute.

Sumir Chadha
Managing Director, Sequoia Capital India
Prior to heading Sequoia Capital India, Sumir founded WestBridge Capital partners which merged with Sequoia Capital USA in early 2006. He was a key member of the Principal Investment Area at Goldman, Sachs & Co, based in New York and Singapore, focused on venture investments in technology before setting up WestBridge Capital. He led or was a key member of the investment team for over 17 technology companies including high profile success stories such as Storage Networks (NASDAQ: STOR), FreeMarkets (NASDAQ: FMKT), webMethods (NASDAQ: WEBM), Centra (NASDAQ: CTRA), Ventro/Chemdex (NASDAQ: VNTR) and TechSpan. These investments totaled over $140 million of private equity capital. His career began as a management consultant at McKinsey & Co. based in New York and New Delhi, where he specialized in the Internet and wireless industries. Sumir is the Chairman of the US-India Venture Capital Association and also a Charter Member of The Indus Entrepreneurs (TiE)'s Silicon Valley chapter. Sumir received an MBA with distinction from Harvard University and a BSE in Computer Science from Princeton University.